Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC

NEW ORLEANS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC), if they purchased or otherwise acquired The Chemours Company securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

GlobeNewsWire • an hour ago

CC Investor Alert: The Chemours Company Securities Class Action Notice - Contact SueWallSt

Important Information Regarding Section 20(a) Individual Liability Claims: The lawsuit names Chemours CEO Denise Dignam and CFO Shane Hostetter as control persons over statements that allegedly overstated Opteon aftermarket demand. It also alleges that the two executives sold more than $485,000 of company stock during the Class Period.

PRNewsWire • 10 hours ago

CC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 29, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company ("The Chemours" or the "Company") (NYSE: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Newsfile Corp • 14 minutes ago

Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers - CC

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

PRNewsWire • 10 hours ago

CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Oct. 29, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP  ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

PRNewsWire • 28 minutes ago

Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - October 29, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the "Class Period").

Newsfile Corp • 7 hours ago

The Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CC

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

PRNewsWire • 2 hours ago

DTCC Launched Tokenization on Canton With Ondo as a Partner. Which Coin Benefits More?

DTCC just launched a tokenization service backed by Fidelity, JPMorgan, and Bank of America, and both Canton Coin and Ondo landed spots in the rollout.

24/7 Wall Street • 21 hours ago

CC Deadline Alert: Levi & Korsinsky Reminds The Chemours Company (CC) Investors of Securities Class Action Deadline on December 7, 2026

Chemours shares shed $3.34 in a single session after a cut to 2026 earnings guidance. The lawsuit alleges that management overstated Opteon aftermarket demand while an oversupplied refrigerant channel weighed on sales.

PRNewsWire • Oct 28, 2026

CC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds The Chemours Investors of Securities Class Action Lawsuit Deadline on December 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 28, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company ("The Chemours" or the "Company") (NYSE: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Newsfile Corp • Oct 28, 2026